Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2020-04-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a public statement from the board of Zhejiang Tailin Biotechnology Co., Ltd. nominating an independent director candidate. It details the qualifications, compliance with regulatory requirements, and declarations related to the nominee's eligibility and independence. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed statements about the nominee's qualifications and compliance, confirming it is not a brief announcement or a regulatory filing.
2020-04-27 Chinese
独立董事候选人声明（董明）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Zhejiang Tailin Biotechnology Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. The content is focused on the candidate's eligibility and suitability for the independent director position, rather than financial data, management changes, or shareholder voting results. It is not a report of financial performance, audit, or earnings, nor is it a notice of voting results or a proxy solicitation. The document is a regulatory compliance statement related to board/management information, specifically concerning the appointment of an independent director candidate. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (6323 characters) and detailed content support this classification with high confidence.
2020-04-27 Chinese
关于提名董明为公司第二届董事会独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the nomination of a new independent director to the company's board, including details about the resignation of a previous independent director and the qualifications of the nominee. It references board decisions and compliance with regulatory guidelines for independent directors. There is no financial data, earnings information, or report publication mentioned. This fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2020-04-27 Chinese
关于公司以自筹资金预先投入募投项目的鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "鉴证报告" (verification report) regarding the company's use of self-raised funds to pre-invest in projects intended to be funded by raised capital. It is issued by an accounting firm and includes statements about the management's responsibility, the scope of the verification work, and the conclusion that the company's disclosures comply with Shenzhen Stock Exchange guidelines. The document is not a full annual or interim financial report but a specific audit-related verification report on a particular capital use matter. It does not contain comprehensive financial statements or management discussion but is a standalone audit verification report. Therefore, it fits the category of Audit Report / Information (AR). The document length is 2470 characters, which is short but contains substantive audit verification content, not just an announcement or certification letter. Hence, it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). FY 2020
2020-04-27 Chinese
关于续聘天健会计师事务所（特殊普通合伙）为公司2020年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of an audit firm (Tianjian Accounting Firm) as the company's auditor for the 2020 fiscal year. It details the qualifications, experience, and independence of the audit firm, the approval process by the board and independent directors, and the need for shareholder approval at the upcoming annual general meeting. The document does not contain actual audited financial statements or audit reports but is a formal announcement about the audit engagement for the upcoming year. The document length is 4048 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information (AR) type, as it relates to audit information and appointment but is not the full annual report or audit report itself. However, given the document is primarily an announcement of the audit firm appointment and related information, it fits the Audit Report / Information category rather than a full Annual Report (10-K) or Regulatory Filing (RNS). FY 2020
2020-04-27 Chinese
第二届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 9th meeting of the 2nd Board of Directors of Zhejiang Tailin Biotechnology Co., Ltd. It includes multiple agenda items such as approval of the 2019 Annual Report, 2020 Q1 Report, financial statements, profit distribution proposals, appointment of auditors, internal control reports, remuneration plans, and other governance-related matters. The document repeatedly states that the detailed reports and documents are published separately on the official disclosure website (cninfo.com.cn) and that these resolutions will be submitted to the 2019 Annual General Meeting for approval. The document is not the reports themselves but a formal board meeting resolution announcement. It contains substantive content about board decisions and management reports but does not include the full financial statements or detailed financial data itself. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management changes or approvals. The document is about board meeting resolutions, not the full annual report or interim report, nor is it a simple announcement of report publication. Therefore, the best classification is MANG with high confidence.
2020-04-27 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.